These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23575422)

  • 21. [Gene therapy and stem cells for the inner ear: a review].
    Breinbauer HA; Praetorius M
    HNO; 2014 Feb; 62(2):93-9. PubMed ID: 24549508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhesus Cochlear and Vestibular Functions Are Preserved After Inner Ear Injection of Saline Volume Sufficient for Gene Therapy Delivery.
    Dai C; Lehar M; Sun DQ; Rvt LS; Carey JP; MacLachlan T; Brough D; Staecker H; Della Santina AM; Hullar TE; Della Santina CC
    J Assoc Res Otolaryngol; 2017 Aug; 18(4):601-617. PubMed ID: 28646272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene transfer in inner ear cells: a challenging race.
    Sacheli R; Delacroix L; Vandenackerveken P; Nguyen L; Malgrange B
    Gene Ther; 2013 Mar; 20(3):237-47. PubMed ID: 22739386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [NT-3 and BDNF for potential inner ear therapy].
    Knipper M
    HNO; 1997 Apr; 45(4):181-3. PubMed ID: 9221253
    [No Abstract]   [Full Text] [Related]  

  • 25. Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction.
    Hastings ML; Jones TA
    Neurotherapeutics; 2019 Apr; 16(2):348-359. PubMed ID: 30972560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics.
    Vlajkovic SM; Thorne PR
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regenerative medicine in the treatment of sensorineural hearing loss].
    Löwenheim H; Waldhaus J; Hirt B; Sandke S; Müller M
    HNO; 2008 Mar; 56(3):288-300. PubMed ID: 18288464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Strategies for development of therapeutics for inner ear disorders according to the stage of degeneration].
    Nakagawa T
    Nihon Yakurigaku Zasshi; 2013 Apr; 141(4):184-7. PubMed ID: 23575421
    [No Abstract]   [Full Text] [Related]  

  • 29. Hyperbaric oxygen therapy for sudden sensorineural hearing loss in divers.
    Van Der Wal AW; Van Ooij PJ; De Ru JA
    J Laryngol Otol; 2016 Nov; 130(11):1039-1047. PubMed ID: 27748209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Stem cells to repair neurosensory deafness?].
    Zine A
    Med Sci (Paris); 2004 May; 20(5):518-20. PubMed ID: 15190468
    [No Abstract]   [Full Text] [Related]  

  • 31. On the Distant Horizon--Medical Therapy for Sensorineural Hearing Loss.
    Kelly KM; Lalwani AK
    Otolaryngol Clin North Am; 2015 Dec; 48(6):1149-65. PubMed ID: 26409822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cochleovestibular gene transfer in neonatal mice by canalostomy.
    Guo JY; Liu YY; Qu TF; Peng Z; Xie J; Wang GP; Gong SS
    Neuroreport; 2017 Aug; 28(11):682-688. PubMed ID: 28614181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell- and gene-therapy approaches to inner ear repair.
    Conde de Felipe MM; Feijoo Redondo A; García-Sancho J; Schimmang T; Durán Alonso MB
    Histol Histopathol; 2011 Jul; 26(7):923-40. PubMed ID: 21630222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hearing loss: Vector overcomes barrier to gene therapy delivery.
    Kingwell K
    Nat Rev Drug Discov; 2017 Mar; 16(4):238-239. PubMed ID: 28356584
    [No Abstract]   [Full Text] [Related]  

  • 35. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
    Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
    Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inner Ear Hearing Loss Part II: Sudden Sensorineural Hearing Loss, Therapeutic Options].
    Hesse G
    Laryngorhinootologie; 2016 Jul; 95(7):461-9. PubMed ID: 27392187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inner ear drug delivery system from the clinical point of view.
    Sakamoto T; Nakagawa T; Horie RT; Hiraumi H; Yamamoto N; Kikkawa YS; Ito J
    Acta Otolaryngol Suppl; 2010 Nov; (563):101-4. PubMed ID: 20879828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deafness: from genetic architecture to gene therapy.
    Petit C; Bonnet C; Safieddine S
    Nat Rev Genet; 2023 Oct; 24(10):665-686. PubMed ID: 37173518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
    Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
    Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel cell-free therapy using exosomes in the inner ear regeneration.
    Amiri M; Kaviari MA; Rostaminasab G; Barimani A; Rezakhani L
    Tissue Cell; 2024 Jun; 88():102373. PubMed ID: 38640600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.